CD44 and breast carcinoma: The greatest portion of a CD44+/CD24− subset was found in the mesenchyme-like breast cancer cell line MDA-MB-231 as described before [8], [19], [20] and this cell line has previously been characterized as having a basal cell phenotype [21].